Kang S - Search Results

1

Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.

Kang S, Kim YB, Kim MH, Yoon KS, Kim JW, Park NH, Song YS, Kang D, Yoo KY, Kang SB, Lee HP. Kang S, et al. Among authors: kang d, kang sb. Cancer Lett. 2005 Jan 10;217(1):11-6. doi: 10.1016/j.canlet.2004.06.053. Cancer Lett. 2005. PMID: 15596291

2

Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women.

Roh JW, Kim MH, Seo SS, Kim SH, Kim JW, Park NH, Song YS, Park SY, Kang SB, Lee HP. Roh JW, et al. Cancer Lett. 2002 Oct 8;184(1):57-63. doi: 10.1016/s0304-3835(02)00193-3. Cancer Lett. 2002. PMID: 12104048

3

Interferon, alpha 17 (IFNA17) Ile184Arg polymorphism and cervical cancer risk.

Kim JW, Roh JW, Park NH, Song YS, Kang SB, Lee HP. Kim JW, et al. Cancer Lett. 2003 Jan 28;189(2):183-8. doi: 10.1016/s0304-3835(02)00548-7. Cancer Lett. 2003. PMID: 12490311

4

Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes.

Kim MH, Seo SS, Song YS, Kang DH, Park IA, Kang SB, Lee HP. Kim MH, et al. Gynecol Oncol. 2003 Jul;90(1):83-90. doi: 10.1016/s0090-8258(03)00224-5. Gynecol Oncol. 2003. PMID: 12821346

5

Multiple HPV infection in cervical cancer screened by HPVDNAChip.

Lee SA, Kang D, Seo SS, Jeong JK, Yoo KY, Jeon YT, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Lee SA, et al. Cancer Lett. 2003 Aug 20;198(2):187-92. doi: 10.1016/s0304-3835(03)00312-4. Cancer Lett. 2003. PMID: 12957357

6

Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.

Seo SS, Song YS, Kang DH, Park IA, Bang YJ, Kang SB, Lee HP. Seo SS, et al. Gynecol Oncol. 2004 Mar;92(3):927-35. doi: 10.1016/j.ygyno.2003.11.055. Gynecol Oncol. 2004. PMID: 14984962

7

p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.

Roh JW, Kim JW, Park NH, Song YS, Park IA, Park SY, Kang SB, Lee HP. Roh JW, et al. Gynecol Oncol. 2004 May;93(2):499-505. doi: 10.1016/j.ygyno.2004.02.005. Gynecol Oncol. 2004. PMID: 15099969

8

[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma.

Kim S, Chung JK, Kang SB, Kim MH, Jeong JM, Lee DS, Lee MC. Kim S, et al. Among authors: kang sb. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):196-201. doi: 10.1007/s00259-003-1367-y. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129701 Clinical Trial.

9

Cyclooxygenase-2 and p53 expressions in endometrial cancer.

Jeon YT, Kang S, Kang DH, Yoo KY, Park IA, Bang YJ, Kim JW, Park NH, Kang SB, Lee HP, Song YS. Jeon YT, et al. Among authors: kang s, kang dh, kang sb. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1538-42. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15342458

10

Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.

Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB, Lee HP. Kang S, et al. Among authors: kang gh, kang sb. Gynecol Oncol. 2005 Jan;96(1):173-80. doi: 10.1016/j.ygyno.2004.09.031. Gynecol Oncol. 2005. PMID: 15589597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,635 results

Search Page

Filters